Category: Therapeutics/pharmacology

W.87 - Prophylaxis with Recombinant Human c1 Inhibitor (rhc1inh) Is Efficacious and Well Tolerated for Prevention of Hereditary Angioedema (hae) Attacks

Wednesday, Jun 14
6:15 PM – 7:45 PM

Bruno M. Giannetti

Department of Clinical Research and Medical Affairs, Pharming Technologies BV
Leiden, Not Applicable, Netherlands

Vesna Grivcheva Panovska

PHU Clinic of Dermatology, Medical University Skopje
Skopje, Not Applicable, Macedonia

H. Henry Li

Institute for Allergy and Asthma
Chevy Chase, Maryland

Dumitru Moldovan

University of Medicine and Pharmacy, Mures County Hospital
Tirgu Mures, Not Applicable, Romania

Marc Riedl

Associate Clinical Professor
University of California, San Diego
San Diego, California

William H. Yang

Ottawa Allergy Research Corporation & University of Ottawa Medical School
Ottawa, Ontario, Canada

Joseph R. Harper

Department of Clinical Research and Medical Affairs, Pharming Technologies BV
Leiden, Not Applicable, Netherlands